Topics
Glioblastoma | Diagnosis | MGMT promoter methylation status
Home > Publications > Topics > Glioblastoma > Diagnosis > MGMT promoter methylation status
Sanada T, Kinoshita M, Sasaki T, Yamamoto S, Fujikawa S, Fukuyama
S, Hayashi N, Fukai J, Okita Y, Nonaka M, Uda T, Arita H, Mori K,
Ishibashi K, Takano K, Nishida N, Shofuda T, Yoshioka E, Kanematsu
D, Tanino M, Kodama Y, Mano M, Kanemura Y.
Prediction
of MGMT promotor methylation status in glioblastoma by
contrast-enhanced T1-weighted intensity image.
Neurooncol
Adv. 2024 Feb 1;6(1):vdae016. doi:
10.1093/noajnl/vdae016. PMID:
38410136. Observational study. ˍ
Liu X, Han T, Wang Y, Liu H, Zhou J.
Prediction
of O(6)-methylguanine-DNA methyltransferase promoter methylation
status in IDH-wildtype glioblastoma using MRI histogram analysis.
Neurosurg
Rev. 2024 Jun 22;47(1):285. doi:
10.1007/s10143-024-02522-w. PMID:
38907038. Observational study˰
ˍ
*Huseyinoglu Z, Uysal E, Inan MA, Demirci T, Gokay G, Aras FK,
Erdamar S, Ozduman K, Pamir MN, Danyeli AE.
Optimal
qMSP cutoff value for MGMT promoter methylation in glioblastoma
and its validation for clinical significance.
BMC
Cancer. 2025 Nov 28;25(1):1833. doi:
10.1186/s12885-025-15225-2. PMID:
41316075. Observational study. ˍ